Harvard Pilgrim Health Care Home
  HPHConnect
 
  Learn more.
  Sign up for HPHConnect.
Medical Management
E-Transactions
HPHConnect
Pharmacy
For Your Patient
News Center
Network Matters
Newsletter Archives
Newsletter Registration
Newsroom
Office Support
Products
Provider Manual
Medicare Advantage
Research & Teaching
Resources & Links
 
Print    Text Size

Network Matters
News and Information for the
Harvard Pilgrim Health Care Network

April 2014

P&T Committee Updates 


At a March 3, 2014 meeting, the Harvard Pilgrim Pharmacy & Therapeutics Committee reviewed several medications and decided the following.

P&T Committee Review and Decisions

Name

Indication

Decision

Quillivant XR
(methylphenidate HCl) 

Quillivant XR is the only extended-release liquid medication currently used to treat Attention Deficit Hyperactivity Disorder (ADHD).

Continued coverage at Tier 3
(Tier 4 for 4-Tier formulary) for commercial products and Tier 4 for Medicare Part D

Strattera
(atomoxetine)
Strattera is a non-stimulant medication used to treat ADHD. 

Moved to Tier 2 (Tier 3 for 4-Tier formulary) for commercial products and Tier 3 for
Medicare Part D

Viibryd
(vilazodone HCl)  
Viibryd is a dual-acting serotonin modulating antidepressant used to treat adults with major depressive disorder. 

Continued coverage at Tier 3 (Tier 4 for 4-Tier formulary) for commercial and Tier 4 for
Medicare Part D

Email this article to a colleague   

Receive Network Matters by e-mail

Network Matters Archives

Download printer-friendly version

HPHCURRENT EVENTS

The Affordable Care Act and Risk Adjustment

CLINICIAN CORNER

Spine Management and Prior Authorization

Medical Policy for Allergy Immunotherapy

Medical Policy for IgG Allergy Testing

Tier Change for Omnitrope and Tev-Tropin

Zostavax Now Available at Retail Pharmacies

P&T Committee Updates

Specialty Pharmacy Updates

Routine Screening for PTSD

OFFICE ASSISTANT

Notifying Harvard Pilgrim of Provider Changes

CMS 1500 (08/05) Form Rejected After June 15

PUBLICATION INFORMATION

Eric H. Schultz,
President and Chief Executive Officer

Richard Weisblatt PhD,
Senior Vice President, Provider Network

Annmarie Dadoly,
Editor

Kristin Edmonston,
Production Coordinator